Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-076554
Filing Date
2015-11-06
Accepted
2015-11-06 11:43:26
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-17822_110q.htm 10-Q 1270785
2 EX-31.1 a15-17822_1ex31d1.htm EX-31.1 12106
3 EX-31.2 a15-17822_1ex31d2.htm EX-31.2 12115
4 EX-32.1 a15-17822_1ex32d1.htm EX-32.1 7304
  Complete submission text file 0001104659-15-076554.txt   7517636

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mnta-20150930.xml EX-101.INS 2134230
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnta-20150930.xsd EX-101.SCH 56854
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnta-20150930_cal.xml EX-101.CAL 47554
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT mnta-20150930_lab.xml EX-101.LAB 488947
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnta-20150930_pre.xml EX-101.PRE 304616
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnta-20150930_def.xml EX-101.DEF 166429
Mailing Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Filer) CIK: 0001235010 (see all company filings)

EIN.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50797 | Film No.: 151203249
SIC: 2836 Biological Products, (No Diagnostic Substances)